Wegovy maker Novo Nordisk to spend $6B boosting production capacity

Most of the new capacity will be dedicated to manufacturing active pharmaceutical ingredients, including for Wegovy and Ozempic, used to treat diabetes and obesity.

Full story

#1

Recent research on Paxlovid shows there is "solid data on its effectiveness," a co-author of the study told HealthLeaders. ...

A new personal protective equipment manufacturing company is set to open in Cincinnati next year. ...